Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma
Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma
复制标题
DOI：
10.1007/s13402-023-00833-6
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
Junmin Li
中科院分区：
文献类型：
--
作者：
Zhen Jin;Rufang Xiang;Kai Qing;Dan Li;Zhao Liu;Xiaoyang Li;Hongming Zhu;Yunxiang Zhang;Lining Wang;Kai Xue;Han Liu;Zizhen Xu;Yingxiao Wang;Junmin Li
